ScryingBiotech,,2019-05-29 14:01:00,0.84,ACST Bought more today in anticipation of Vascepa approval Far less concerned now about regulatory shenanigans Granting Priority Review then scuttling the application would be beyond absurd
zippy82,,2019-05-29 11:07:00,0.8478,ACST Surprised this isnt getting dragged along with AMRN I guess theres just too much money flow going that way
Mhornick,,2019-05-29 10:55:00,0.8478,ACST anyone done some dd on MatinasMatinas Bio up 4 premarket on bullish call at BTIG seekingalphacomnews34649
RisingPhoenix,,2019-05-29 10:52:00,0.8499,ACST Imagine what will happen to the share price when WS realizes CaPre is more efficient that Vacepa to lower TG decrease LDL while increasing HDL at the same time Current market cap of 70M vs 66B for Amarin or 100X bigger
KGB_Putin,True,2019-05-29 10:34:00,0.8499,ACST We got priority review for V not its a time for ACST hit 3 in no time
KGB_Putin,True,2019-05-29 10:15:00,0.8438,ACST AMRN has 63bln MC with yearly revenue about 350mln but Acasti MC still bellow 100mln What is going on here Something isnt right
KGB_Putin,True,2019-05-29 09:50:00,0.8255,ACST Amarin got the priority review finally
